Valerie DeBenedette

Update: Recall expanded to Natural Ophthalmics and TRP Company, Inc. 

25 murder charges against one physician leads to multiple firings at Ohio hospital.

CVS will expand its health offerings, including nutrition and weight loss.

Both pharmacy groups state that rule should have addressed DIR fees.

Suit filed in Connecticut alleges companies conspired to inflate prices on more than 100 generic drugs.

The company is donating enough drugs for 200,000 patients for up to 11 years, but does it make up for the high price of the drug?

Premier is exiting the specialty pharmacy market and selling its ProCare Pharmacy company.

Two different versions of tafamadis get the FDA’s nod to treat a rare heart disease. 

First vaccine approved for all four Dengue virus serotypes in children and teens ages 9 through 16, but comes with major restrictions and controversy.

Diacomit (stiripentol) is indicated for rare, severe form of pediatric epilepsy.

Alvogen, Inc., has issued a recall of two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level.

Safety alert issued requiring warning about concurrent alcohol use.

 The average price of generics is about one-eighteenth the price of the brand product.

Consumers are using test strips that might lead to inaccurate results. 

The chain will use Shipt to deliver prescriptions from 6,000 locations. 

400 positions consolidated, saving a predicted annual $55 million.

ADA violations net pharmacist over $1 million. 

Higher-dose tofacitinib linked to greater risk of pulmonary embolism in RA patients.

New app may improve directly observed therapy adherence for TB, opioid abuse treatment, and diabetes.

FDA, CDC, and DEA are still supporting pharmacists during the federal shutdown

Over the course of a century, Paulsen’s Pharmacy has been providing medications and care to the people of Portland, OR.

2018 marks the 100th anniversary of the Spanish Flu Pandemic, one of the worst pandemics in global history.

Sterility concerns warrant warning from FDA to healthcare providers to stop using products produced by Pharm D. 

Tall man lettering is supposed to help reduce medication errors-but some say it doesn’t go far enough.

What the experts have to say about recent shifts in pharmacy law and practice.

If pharmacies want to succeed, they'll need to adapt.